Fructooligosaccharides (FOS) 用于 Chronic Constipation
CSome studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'gutcited.com';
const params = 'ingredient\u003Dfructooligosaccharides\u0026condition\u003Dconstipation';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
C
结论
Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.
Key Study Findings
Review
Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions.
Dose: None
vs: None
Outcome: gut health outcomes including microbiota modulation and SCFA …
效果: None
None
研究人群: healthy individuals, children, elderly, and those with constipation, metabolic syndrome, or dysbiosis
Randomized Controlled Trial
n=67
4 weeks
Double-blind
Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with …
Dose: None
vs: Placebo
Outcome: Weekly spontaneous bowel movements
效果: 4.94 vs 3.00 (P<0.001)
P<0.001
研究人群: Older adults >=60 with functional constipation (Rome IV)
Other
Maternal or post-weaning dietary fructo-oligosaccharide supplementation reduces stillbirth rate of sows and diarrhea of weaned …
Dose: 2 g
vs: None
Outcome: Constipation symptoms
效果: None
P < 0.05
研究人群: Constipation patients
Randomized Controlled Trial
Double-blind
Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium.
Dose: 6 g
vs: Placebo
Outcome: Constipation symptoms
效果: None
None
研究人群: Constipation patients
Systematic Review
Fructooligosaccharides for Relieving Functional Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Dose: None
vs: None
Outcome: Constipation symptoms
效果: OR: 10.36
p < 0.00001
研究人群: Constipation patients
Randomized Controlled Trial
Double-blind
Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics.
Dose: None
vs: Placebo
Outcome: Constipation symptoms
效果: None
None
研究人群: Constipation patients
Key Statistics
4
研究数量
350
受试者
↑
Positive
C
等级
Referenced Papers
Nutrients
2026
1 次引用
The journal of …
2025
Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium.
Other
Food science & …
2024
17 次引用
Foods (Basel, Switzerland)
2024
8 次引用
Journal of Parkinson's …
2024
4 次引用
Animal nutrition (Zhongguo …
2024
4 次引用
Carbohydrate polymers
2022
77 次引用
Frontiers in nutrition
2022
22 次引用
Nutrients
2019
35 次引用
Nutrients
2018
30 次引用
Journal of the …
2017
447 次引用
Neurogastroenterology and motility
2017
131 次引用
Nutrients
2017
28 次引用
Clinical nutrition (Edinburgh, …
2017
20 次引用
Peritoneal dialysis international …
2016
38 次引用
World journal of …
2014
16 次引用
Clinical nutrition (Edinburgh, …
2013
Nutrition (Burbank, Los …
2011
65 次引用
Journal of medicinal …
2011
24 次引用
Journal of physiology …
2009
312 次引用
Journal of the …
2007
84 次引用
BioFactors (Oxford, England)
2004
48 次引用
The British journal …
2003
97 次引用
Journal of renal …
1998
71 次引用
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 2-10 g/day
- prebioticeffect:
- 5-8 g/day for bifidogenic effect
- constipationsupport:
- 5-10 g/day
上限： Well-tolerated up to 20 g/day; start low to avoid excess gas
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | 4 weeks | Positive | 67 |
| 2 g | -- | Neutral | -- |
| 6 g | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
最佳服用时间： With meals; divide doses throughout the day
Safety & Side Effects
已报告的副作用
- ⚠ Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day)
- ⚠ Abdominal cramping at higher doses
- ⚠ May worsen IBS symptoms in FODMAP-sensitive individuals
- ⚠ Loose stools at excessive doses
已知相互作用
- ● Other FODMAPs (cumulative fermentation effect in sensitive individuals)
- ● Blood sugar-lowering medications (FOS may modestly affect glycemic response)
- ● Calcium supplements (FOS may enhance calcium absorption)
可耐受最高摄入量： Well-tolerated up to 20 g/day; start low to avoid excess gas
在开始服用任何补充剂之前，请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Fructooligosaccharides (FOS) help with Chronic Constipation?
Based on 4 studies with 350 participants, there is limited but promising evidence that Fructooligosaccharides (FOS) may support Chronic Constipation management. Our evidence grade is C (Some Evidence).
How much Fructooligosaccharides (FOS) should I take for Chronic Constipation?
Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Fructooligosaccharides (FOS)?
Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Fructooligosaccharides (FOS) and Chronic Constipation?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.
Related Evidence
其他成分用于 Chronic Constipation
Fructooligosaccharides (FOS) 用于其他健康状况
FDA 免责声明: 这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。